Patent Assignment
Reel/Frame 033914/0137
Assignment of Assignor's Interest
Recorded: 2014-10-08
Pages: 3
Assignee
ALETHIA BIOTHERAPEUTICS INC.
141 PRESIDENT-KENNEDY AVE., SUITE SB-5100, MONTREAL, H2X 1Y4, CANADA
Covered Property
(1)
Anti-Clusterin Antibodies and Antigen Binding Fragments and Their Use to Reduce Tumor Volume
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 8, 2014
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 033914/0059 →
License
Mar 25, 2015
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 035251/0608 →
Change of Name
Aug 25, 2025
From: ALETHIA BIOTHERAPEUTICS INC.
To: ALETHIA BIOTHERAPEUTICS ULC
Reel/Frame 072107/0559 →